Yayın:
Caffeine use in preterm neonates: National insights into Turkish NICU practices

dc.contributor.authorUnal, Sezin
dc.contributor.authorBeken, Serdar
dc.contributor.authorInce, Deniz Anuk
dc.contributor.authorTuran, Ozden
dc.contributor.authorToygar, Ayse Korkmaz
dc.contributor.authorEcevit, Ayse
dc.contributor.authorAkcan, Abdullah Baris
dc.contributor.authorAkin, Mustafa Ali
dc.contributor.authorAktas, Selma
dc.contributor.authorCiftdemir, Nukhet Aladag
dc.contributor.authorAltuncu, Emel
dc.contributor.authorAltunhan, Huseyin
dc.contributor.authorArcagok, Baran Cengiz
dc.contributor.authorArmangil, Didem
dc.contributor.authorOzer, Esra Arun
dc.contributor.authorAydin, Banu
dc.contributor.authorBezirganoglu, Handan
dc.contributor.authorBilgin, Leyla
dc.contributor.authorCalisici, Erhan
dc.contributor.authorCalkavur, Sebnem
dc.contributor.authorCelik, Kiymet
dc.contributor.authorCelik, Yalcin
dc.contributor.authorCetinkaya, Bilin
dc.contributor.authorCetinkaya, Merih
dc.contributor.authorDemirel, Atalay
dc.contributor.authorDemirel, Gamze
dc.contributor.authorDogan, Nazan Neslihan
dc.contributor.authorDogan, Pelin
dc.contributor.authorDurukan, Mehtap
dc.contributor.authorEngur, Defne
dc.contributor.authorErcan, Tugba Erener
dc.contributor.authorGokmen, Zeynel
dc.contributor.authorVaral, Ipek Guney
dc.contributor.authorGulasi, Selvi
dc.contributor.authorGunlemez, Ayla
dc.contributor.authorGursoy, Tugba
dc.contributor.authorToptan, Handan Hakyemez
dc.contributor.authorHamitoglu, Serif
dc.contributor.authorIsleyen, Fatih
dc.contributor.authorIyigun, Irem
dc.contributor.authorKader, Sebnem
dc.contributor.authorKahvecioglu, Dilek
dc.contributor.authorKayki, Gozdem
dc.contributor.authorKostu, Murat
dc.contributor.authorKurnaz, Dilek
dc.contributor.authorMammadaliyev, Tural
dc.contributor.authorAkin, Ilke Mungan
dc.contributor.authorNarli, Nejat
dc.contributor.authorOkulu, Emel
dc.contributor.authorOkur, Nilufer
dc.contributor.authorOlukman, Ozgur
dc.contributor.authorOvali, Fahri
dc.contributor.authorOzcan, Beyza
dc.contributor.authorOzdemir, Ahmet
dc.contributor.authorOzdemir, Ozmert
dc.contributor.authorOzkan, Hilal
dc.contributor.authorSandal, Gonca
dc.contributor.authorSarici, Dilek
dc.contributor.authorSivrikaya, Cansu
dc.contributor.authorBilgin, Betul Siyah
dc.contributor.authorSundus, Saime
dc.contributor.authorOnay, Ozge Surmeli
dc.contributor.authorSimsek, Huseyin
dc.contributor.authorTandircioglu, Umit Ayse
dc.contributor.authorTanriverdi, Sema
dc.contributor.authorTekgunduz, Kadir Serafettin
dc.contributor.authorTerek, Demet
dc.contributor.authorTunc, Gaffari
dc.contributor.authorTunc, Turan
dc.contributor.authorTutak, Ercan
dc.contributor.authorTufekcioglu, Eda
dc.contributor.authorErdogan, Funda Tuzun
dc.contributor.authorUlu, Ersin
dc.contributor.authorIsik, Dilek Ulubas
dc.contributor.authorUras, Nurdan
dc.contributor.authorUslu, Sait Ilker
dc.contributor.authorUnal, Irem
dc.contributor.authorYilmaz, Fatma Hilal
dc.contributor.authorMoniri, Ariorad
dc.contributor.buuauthorÖZKAN, HİLAL
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentÇocuk Sağlığı ve Hastalıkları Ana Bilim Dalı
dc.contributor.researcheridIGT-7005-2023
dc.date.accessioned2025-10-21T10:10:23Z
dc.date.issued2025-02-27
dc.description.abstractObjective: Caffeine is a proven medication used for the prevention and treatment of apnea in premature infants, offering both short- and long-term benefits. International guidelines provide a range of recommendations regarding the preterm population eligible for caffeine prophylaxis, including the timing, dosage, and duration of treatment. Our national guidelines, published prior to the most recent updates of the international guidelines, recommend the use of caffeine citrate starting from the first day after delivery for preterm infants with a gestational age of <28 weeks. For infants up to 32 weeks, if positive pressure ventilation is required, the decision should be made on an individual basis. This study aims to describe the variability in caffeine usage across neonatal intensive care units in our country. Methods: An online survey was sent to neonatologist who are members of the Turkish Neonatology Society to describe the variability in caffeine usage in neonatal intensive care units in our country. Results: We collected responses from 74 units. Prophylactic caffeine usage was observed as; GA <= 27(6/7): 98.6%, GA 28(0/7)-28(6/7): 89.0%, GA 29(0/7)-29(6/7): 75.3%, GA 30(0/7)-31(6/7): 53.4%. 62.2% of units reported administering loading dose within the first two hours. The initial maintenance dose was 5 mg/kg in 64.8% of units, 10 mg/kg in 32.4% of units, and intermediate dose in 5.3% of units. 47.3% of units reported no routine dose adjustment. The postmenstrual age that caffeine treatment was stopped was found to be 34 (min-max; 32-36) weeks for infants without apnea and respiratory support, 36 (min-max; 34-52) weeks for infants without apnea but any respiratory support. The time to discharge after treatment cessation was found as; 1-4 days: 37.8%, 5-7 days: 68.9%. Among the 56 units with multiple responsible physicians, 32.1% reported intra-unit variations. Conclusion: The significant differences in caffeine usage characteristics between and within units highlight the need for clear recommendations provided by standardized guidelines.
dc.identifier.doi10.3389/fped.2025.1492716
dc.identifier.issn2296-2360
dc.identifier.scopus2-s2.0-105008507361
dc.identifier.urihttps://doi.org/10.3389/fped.2025.1492716
dc.identifier.urihttps://hdl.handle.net/11452/56386
dc.identifier.volume13
dc.identifier.wos001443933100001
dc.indexed.wosWOS.SCI
dc.language.isoen
dc.publisherFrontiers Media
dc.relation.journalFrontiers in Pediatrics
dc.subjectDose caffeine
dc.subjectBronchopulmonary dysplasia
dc.subjectIntermittent hypoxia
dc.subjectPremature-infants
dc.subjectApnea
dc.subjectTherapy
dc.subjectCitrate
dc.subjectOutcomes
dc.subjectBirth
dc.subjectPrevention
dc.subjectCaffeine
dc.subjectPremature neonate
dc.subjectApnea of prematurity
dc.subjectNeonatal intensive care unit
dc.subjectGuideline
dc.subjectPediatrics
dc.subjectScience & Technology
dc.subjectLife Sciences & Biomedicine
dc.titleCaffeine use in preterm neonates: National insights into Turkish NICU practices
dc.typeArticle
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Çocuk Sağlığı ve Hastalıkları Ana Bilim Dalı
local.indexed.atWOS
local.indexed.atScopus
relation.isAuthorOfPublication67242d15-556e-43b2-a23e-e80ce158b468
relation.isAuthorOfPublication.latestForDiscovery67242d15-556e-43b2-a23e-e80ce158b468

Dosyalar